This study aimed to compare the clinical and angiographic outcomes of patients with DES-ISR who underwent repeat PCI with intravascular imaging or angiographic guidance.
Through early revascularization, percutaneous coronary intervention (PCI) and following pharmacotherapy have improved clinical prognosis among patients with coronary artery disease. However, the presence of stent failure events remained posing long-term risk of adverse cardiac events. Although the utilization of drug-eluting stents (DES), the incidence of in-stent restenosis (ISR) continued to occur at an incidence rate of 1-2% annually. Also, the prognosis of ISR was worse than that in denovo lesions considering its complex mechanisms(stent under-expansion, neointimal hyperplasia or neo-atherosclerosis).Compared with coronary angiography, intravascular imaging(OCT/IVUS) provides detailed anatomical information regarding reference vessel dimensions and lesion characteristics, including severity of diameter stenosis, lesion length, and morphology. Identifying the mechanism of stent failure is paramount because the causative factors will influence the selection of treatment strategy, ultimately impacting the prognosis of the revascularization. However, clinical evidence for the exact benefit of intravascular imaging-guidance for ISR lesions is limited. Therefore, this study aimed to compare the efficacy and safety of intravascular imaging -guided PCI in patients with ISR.
Study Type
OBSERVATIONAL
Enrollment
1,500
Percutaneous Coronary Intervention for ISR
Nanjing First Hospital
Nanjing, Jiangsu, China
RECRUITINGMACE
Major adverse cardiovascular events following PCI
Time frame: 3-year
Stent expansion
defined as the final minimal luminal area (MLA) within the treatment segment divided by the average reference vessel area
Time frame: Intraprocedural
MSA
minimal stent area
Time frame: Intraprocedural
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.